GlassScriptPhysician profile
Patricia Henry
NPI 1629308663
$3,790.49
in general payments reported to CMS, 2019-2025
18 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.61 · 2020: $104 · 2021: $299 · 2022: $2,235 · 2023: $667 · 2024: $38.31 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $1,947.61 | 2022 | |
| Abbvie INC. | $638.93 | 2020-2023 | |
| Conmed Corporation | $306.07 | 2023-2025 | Conmed Biliary, Conmed Generators |
| Medtronic, INC. | $246.51 | 2021-2023 | Gi Genius |
| Boston Scientific Corporation | $181.91 | 2024-2025 | General - Therapies |
| Phathom Pharmaceuticals, INC. | $115.62 | 2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $107.14 | 2022 | |
| Daiichi Sankyo INC. | $94.24 | 2019-2023 | Injectafer |
| Qol Medical, LLC | $30.83 | 2022-2023 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $29.17 | 2021-2023 | Gattex |
| Nestle Healthcare Nutrition INC. | $25.13 | 2023 | |
| Ferring Pharmaceuticals INC. | $19.65 | 2022 | |
| Celgene Corporation | $17.17 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.46 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.05 | 2023 | Givlaari |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.